ethosuximide has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, J | 1 |
| Wang, Z | 1 |
| Dong, Y | 1 |
| Yang, Y | 1 |
| Ng, CH | 1 |
| Ma, S | 1 |
| Xu, Y | 1 |
| Hu, H | 1 |
| Hu, S | 1 |
1 trial available for ethosuximide and Depressive Disorder, Treatment-Resistant
| Article | Year |
|---|---|
A statistical analysis plan for a randomized clinical trial to evaluate the efficacy and safety of ethosuximide in patients with treatment-resistant depression.
Topics: Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Ethosuximide; | 2019 |